Drug Approval | March 19, 2023
Bliss GVS Pharma gets 3 minor observations from USFDA for Palghar unit
The observations are procedural in nature
The observations are procedural in nature
He is Proficient in overseeing and leading teams for running successful business operations
Mindset disagrees with and denies the allegations set forth from Reunion.
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
She was the CEO of Tata Insights and Quants a Division of the Tata Industries Ltd.
Rocuronium Bromide Injection is a neuromuscular blocking agent
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.
Receives regulatory approval for its molecule ‘Selumetinib’ in India
Subscribe To Our Newsletter & Stay Updated
